Report Sellers has added a new market research report “Blood Culture Test – Global Market Outlook (2017-23)” to its offerings.
According to Report, the Global Blood Culture Test market is expected to grow from $3.01 billion in 2016 to reach $5.65 billion by 2023 with a CAGR of 9.4%. Rising new product launches & number of regulatory approvals, increasing sepsis cases, increasing incidence of bloodstream infections, growing R&D investments for development of the novel testing products and turning demand for rapid diagnostic techniques are some of the factors boosting the market growth. In addition, growing geriatric population and high predominance of infectious diseases are the other key factors promoting the market growth. However, shortage of trained laboratory technicians and huge price of automated instruments are hindering the market growth.
Based on the technologies, molecular technologies segment is expected to grow with a high CAGR during in the forecast period. Molecular technologies have a significant growth due to the factors such as rising incidence of sepsis that calls for speedy diagnostic techniques for finding the presence of mycobacteria, fungi and bacteria from blood samples. By end users, reference laboratories segment is expected to grow at the highest CAGR in the forecast period. Reference Laboratories are the developing source of blood culture tests in hospitals. They are outfitted with advanced diagnostic techniques that offer blood culture tests with a quick turnaround time.
North America represents as the largest market in terms of revenue due to the local existence of multinational healthcare companies like BioMrieux SA, Roche Diagnostics, Dickinson & Company and Becton. Asia Pacific is expected to witness a brisk market growth over the forecast period. Circumstances like government actions to raise realization on the disease in public and rising awareness about early disease diagnosis are the major factors for the market growth in this region.
Some of the key players in global blood culture test market include Becton, Dickinson and Company, Alere Inc., Thermo Fisher Scientific, Inc., Cepheid, Nanosphere, Inc., Bruker Corporation, Beckman Coulter, Roche Diagnostics, Iridica, T2 Biosystems, Siemens, Nanosphere Inc., BioMerieux SA and Luminex Corporation.
Browse through the complete description and in-depth TOC on “Global Blood Culture Test Market”
What does the Report Offers
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
Global Blood Culture Market has been segmented by applications covered, technologies covered, methods covered, products covered, end users covered and regions covered
Software and Services
End Users Covered:
Academic Research Laboratories
Other End Users
Rest of Europe
Rest of Asia Pacific
Rest of South America
Middle East & Africa
Rest of Middle East & Africa
We have a large number of reports in Healthcare Industry which can be accessed in the following link: https://www.reportsellers.com/category/healthcare-market-research-report
About Report Sellers
Report Sellers is a premium market research service provider offering market reports in varied sectors. We have a team of experienced analysts and publishers who continuously track the latest trends in different industries. Report Sellers is a brand of global repute and offers the best suited research services to its clients globally in the most satisfying manner. We have a strong network of industry experts who have successfully delivered complex research assignments in niche and top markets.
For more information, contact